Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?

被引：2

作者：

Popovic, Djordje S. ^{[1
,2
]}

Patoulias, Dimitrios ^{[1
]}

Koufakis, Theocharis ^{[2
]}

Stavropoulos, Konstantinos ^{[2
]}

Karakasis, Paschalis ^{[3
]}

Ruza, Ieva ^{[4
]}

Papanas, Nikolaos ^{[5
]}

Rizzo, Manfredi ^{[6
]}

Doumas, Michael ^{[2
]}

机构：

[1] Univ Novi Sad, Med Fac, Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia

[2] Aristotle Univ Thessaloniki, Gen Hosp Hippokration, Propedeut Dept Internal Med 2, Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, Gen Hosp Hippokration, Dept Cardiol 2, Thessaloniki, Greece

[4] Riga Eastern Clin Univ Hosp, Dept Endocrinol, Riga, Latvia

[5] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Diabet Ctr, Dept Internal Med 2, Alexandroupolis, Greece

[6] Univ Palermo, Sch Med, Dept Hlth Promot Mother & Child Care Internal Med, Palermo, Italy

来源：

JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2024年 / 38卷 / 08期

关键词：

Tirzepatide; Type; 2; diabetes; Normoglycemia; INSULIN GLARGINE; GLYCEMIC CONTROL; DOUBLE-BLIND; MANAGEMENT; PLACEBO; GLP-1; GIP;

D O I：

10.1016/j.jdiacomp.2024.108800

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We sought to determine whether treatment with tirzepatide in type 2 diabetes mellitus (T2DM) patients can increase the odds for achieving normoglycemia, compatible with glycated hemoglobin levels lower than 5.7 %. We demonstrated that treatment with tirzepatide versus control increased the odds for achievement of normoglycemia by >16 times.

引用

页数：3

共 50 条

[1] Drug-induced hypoglycaemia in type 2 diabetes
Inkster, Berit
Zammitt, Nicola N.
Frier, Brian M.
EXPERT OPINION ON DRUG SAFETY, 2012, 11 (04) : 597 - 614
[2] The effectiveness and value of tirzepatide for type 2 diabetes mellitus
Nikitin, Dmitriy
Lin, Grace A.
Campbell, Jon D.
Hansen, Ryan N.
Brouwer, Elizabeth
Chen, Yilin
Herron-Smith, Serina
Agboola, Foluso
Pearson, Steven D.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 680 - 684
[3] Tirzepatide (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus
Rebitch, Catherine B.
AMERICAN FAMILY PHYSICIAN, 2023, 108 (01) : 93 - 94
[4] Remission of type 2 diabetes mellitus
Nakhleh, Afif
Halfin, Elya
Shehadeh, Naim
WORLD JOURNAL OF DIABETES, 2024, 15 (07)
[5] Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond
Dutta, Palak
Kumar, Yashaank
Babu, Alexis T.
Ravindran, Suganya Giri
Salam, Ajal
Rai, Bhumish
Baskar, Aakash
Dhawan, Ananya
Jomy, Manjima
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
[6] Near-Normoglycemia and Insulin Regression Induced by Tirzepatide in Basal Insulin-Treated Type 2 Diabetes
Rosenstock, Julio
Tofe, Santiago
Wysham, Carol H.
Thieu, Vivian
Kiljanski, Jacek I.
Lee, Clare
Wang, Hui
Patel, Hiren
DIABETES, 2024, 73
[7] Is remission of type 2 diabetes mellitus real?
Stranks, Stephen N.
Wittert, Gary A.
MEDICAL JOURNAL OF AUSTRALIA, 2023, 219 (10) : 448 - 450
[8] Tirzepatide for type 2 diabetes
Anderson, Sarah L.
Marrs, Joel C.
DRUGS IN CONTEXT, 2023, 12
[9] Frequency and Predisposing Factors for Drug-Induced Hypoglycemia in Patients with Type-2 Diabetes Mellitus
Sharif, Atiqulla
Sridhar, Sathvik Belagodu
Bittar, Hana Rami
Hamad, Ahed
Ahmed, Reem
Kadour, Ghaidaa
JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2019, 8 (02) : 64 - 68
[10] DRUG-INDUCED DIABETES
VERBOV, J
LANCET, 1965, 2 (7408): : 388 - &

← 1 2 3 4 5 →